Zimmer Biomet Holdings (ZBH) FCF Margin (2009 - 2026)
Zimmer Biomet Holdings' (ZBH) quarterly FCF Margin came in at 15.48% in Q1 2026, down 223.0% year-on-year from 12.59% in Q1 2025, and down 21.5% quarter-over-quarter from 19.73% in Q4 2025.
Zimmer Biomet Holdings (ZBH) FCF Margin (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' FCF Margin history runs 18 years deep, the most recent figure standing at 15.48% for Q1 2026.
- On a quarterly basis, FCF Margin fell 223.0% year-over-year to 15.48% in Q1 2026; TTM through Mar 2026 was 17.33%, a 164.0% decrease from a year earlier, with the FY2025 full-year figure at 17.89%, up 102.0% from the prior year.
- FCF Margin eased to 15.48% in Q1 2026 per ZBH's latest filing, from 19.73% in the prior quarter.
- Across five years, FCF Margin topped out at 27.09% in Q4 2023 and bottomed at 9.15% in Q1 2024.
- The 5-year median for FCF Margin is 16.79% (2022), against an average of 17.13%.
- Biggest YoY gain for FCF Margin was 1719 bps in 2023; the steepest drop was 973 bps in 2023.
- Year by year, FCF Margin stood at 9.91% in 2022, then soared by 173 bps to 27.09% in 2023, then decreased by 17 bps to 22.48% in 2024, then fell by 12 bps to 19.73% in 2025, then fell by 22 bps to 15.48% in 2026.
- Per Business Quant, the three latest ZBH FCF Margin figures stand at 15.48% (Q1 2026), 19.73% (Q4 2025), and 18.17% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -1.28% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 37.67% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.68% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.18% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Zimmer Biomet Holdings | 17.48 Bn | 17.07 Bn | 1.51 Bn | 15.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.48% |
| Dec 31, 2025 | 19.73% |
| Sep 30, 2025 | 18.17% |
| Jun 30, 2025 | 15.79% |
| Mar 31, 2025 | 17.72% |
| Dec 31, 2024 | 22.48% |
| Sep 30, 2024 | 19.25% |
| Jun 30, 2024 | 16.31% |
| Mar 31, 2024 | 9.15% |
| Dec 31, 2023 | 27.09% |
| Sep 30, 2023 | 14.44% |
| Jun 30, 2023 | 13.40% |
| Mar 31, 2023 | 14.25% |
| Dec 31, 2022 | 9.91% |
| Sep 30, 2022 | 24.17% |
| Jun 30, 2022 | 17.10% |
| Mar 31, 2022 | 16.79% |
| Dec 31, 2021 | 16.23% |
| Sep 30, 2021 | 22.56% |
| Jun 30, 2021 | 22.37% |